Evaluation of Genetics of Obesity and MC4R Deficiency: A Gene-oriented Approach to Obesity

Onur Oral (Ege University Faculty of Sports Sciences, Department of Health Sciences and Sports, Izmir, Turkey)
George Nomikos (Chios Hospital, Department of Orthopaedic Surgery, Chios, Greece)
Nikitas Nomikos (Medical School & School of Physical Education and Sport Science, National & Kapodistrian University of Athens,Greece)

Article ID: 2977

Abstract


Obesity is a multifactorial and complex health problem that is affected by several factors including genetic, environmental, social,behavioural, and biological aspects. Even though the influence of other environmental and behavioural factors such as sedentary lifestyle, high-calorie nutritional intake, and the inadequate expenditure of energy are acknowledged as important aspects that cause obesity, the issue of inheritance is indisputable. The study aims to investigate the effects of inheritance on obesity and examine how understanding and detecting genetic reasons behind obesity may benefit the treatment and prevention of the obesity epidemic. The relationship between common gene variants and obesity is now being studied through the emergence of GWAS. It is undeniable that genetic mutations and gene deficiencies particularly MC4R deficiency are significant factors. The process of detecting genes that create a tendency to obesity is currently being studied. It may be possible to prevent and treat obesity with the detection of certain genes.


Keywords


Obesity;Genetics of obesity;MC4R;Mutation

Full Text:

PDF

References


[1] Ng, M., Fleming, T., Robinson, M., Thomson, B.,Graetz, N., Margono, C.et al. (2014). Global,regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet; 384: 766-781.

[2] Bluher, M. (2016). Adipose tissue inflammation: a cause or consequence of obesity-related insulin resistance?.Clin Sci (Lond).; 130: 1603-1614.

[3] Long, E., Beales, I.L. (2014). The role of obesity in oesophageal cancer development.Ther Adv Gastroenterol; 7: 247-268.

[4] Rosso, N., Chavez-Tapia, N.C., Tiribelli, C., Bellentani, S. (2014).Translational approaches: from fatty liver to non-alcoholic steatohepatitis.World J Gastroenterol; 20: 9038-9049.

[5] Nomikos NN, Nikolaidis PT, Sousa CV, Papalois AE, Rosemann T, Knechtle B. Exercise, Telomeres,and Cancer: “The Exercise-Telomere Hypothesis”.Front Physiol. 2018;9:1798. Published 2018 Dec 18.DOI:10.3389/fphys.2018.01798.

[6] Nomikos, N., Trompoukis, C., Lamprou, C., & Nomikos, G. (2016). The Role of Exercise in Hippocratic Medicine. American Journal of Sports Science and Medicine, 4(4), 115-119.

[7] Nomikos, N., Lamprou C. (2021). Proceedings of 47 Panhellenic Medical Congress. The reports about dietary and exercise in the texts of Hippocrates.

[8] Chung, W.K., Leibel, R.L. (2008). Considerations regarding the genetics of obesity. Obesity (Silver Spring). Suppl 3:S33-9.

[9] Wood, A.C. (2018). Appetitive Traits: Genetic Contributions to Pediatric Eating Behaviors. In:Pediatric Food Preferences and Eating Behaviors. Elsevier;127-146.

[10] Scuteri, A., Sanna, S., Chen, W.M., et al. (2007). Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet, 3:e115.

[11] Xiang, L., Wu, H., Pan, A., et al. (2016). FTO genotype and weight loss in diet and lifestyle interventions: a systematic review and meta-analysis, 2. Am J Clin Nutr. ;103(4):1162-1170.

[12] Herrera B.M., Lindgren C.M. (2010). The Genetics of Obesity. Curr Diab Rep 10:498–505 DOI 10.1007/s11892-010-0153-z.

[13] Thaker V. V. (2017). Genetic And Epigenetic Causes Of Obesıty. Adolescent medicine: state of the art reviews, 28(2), 379-405.

[14] Mangum, B.P., Mangum, T.L. (2018). Gene-environment interactions and the genetic epidemiology of obesity: correlates for preventative medicine. J Obes Metab Disord.;1(1):25-28.

[15] Torres, K. Y. (2010). Chronic Disease Epidemiology and Control, 3rd Edition. Preventing Chronic Disease, 8(1), A25.

[16] Scuteri, A., Sanna, S., Chen, W.M., et al. (2007). Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet, 3:e115.

[17] Frayling, T.M., Timpson, N.J., Weedon, M.N., et al.(2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science,316:889-894.

[18] International HapMap Consortium (2005). A haplotype map of the human genome. Nature,437:1299-1320.

[19] Barrett, J.C., Cardon, L.R. (2006). Evaluating coverage of genome-wide association studies. Nat Genet,38:659-662.

[20] Pe’er, I., de Bakker, P.I., Maller, J., et al. (2006).Evaluating and improving power in whole-genome association studies using fixed marker sets. Nat Genet, 38:663-667.

[21] LeRoith, D., Taylor, S.I., and Olefsky, J.M. (2004).Diabetes Mellitus: A Fundamental and Clinical Text (3rd Ed.) Lippincott Williams & Wilkins.

[22] Mountjoy, K.G., Wong, J. (1997). Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol.;128(1-2):171-7.

[23] Fan, W., Boston, B.A., Kesterson, R.A., Hruby, V.J.,Cone, R.D. (1997). Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature. ;385(6612):165-8.

[24] Nowacka-Woszuk, J., Cieslak, J., Skowronska, B., et al. (2011). Missense mutations and polymorphisms of the MC4R gene in Polish obese children and adolescents in relation to the relative body mass index. J Appl Genet.;52(3):319-23.

[25] Wangensteen, T., Kolsgaard, M.L.P., Mattingsdal, M.,et al. (2009). Mutations in the melanocortin 4 receptor (MC4R) gene in obese patients in Norway. Exp Clin Endocrinol Diabetes.;117(6):266-73.

[26] Stutzmann, F., Tan, K., Vatin, V., et al. (2008). Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. iabetes.;57(9):2511-8.

[27] Elks, C.E., Den Hoed, M., Zhao, J.H., et al. (2012).Variability in the heritability of body mass index: a systematic review and meta-regression. Front Endocrinol.;3:29.

[28] Silventoinen, K., Jelenkovic, A., Sund, R., et al.(2017). Differences in genetic and environmental variation in adult BMI by sex, age, time period, and region: an individual-based pooled analysis of 40 twin cohorts. Am J Clin Nutr.;106(2):457-466.

[29] Llewellyn, C., Wardle, J. (2015). Behavioral susceptibility to obesity: gene– environment interplay in the development of weight. Physiol Behav.;152:494–501.

[30] Allison, D.B., Kaprio, J., Korkeila, M., Koskenvuo,M., Neale, M.C., Hayakawa, K. (1996).The heritability of body mass index among an international sample of monozygotic twins reared apart. Int J Obes Relat Metab Disord.; 20: 501-506.

[31] Katzmarzyk, P.T., Perusse, L., Rao, D.C., Bouchard,C. (2000). Familial risk of overweight and obesity in the Canadian population using the WHO/NIH criteria. Obes Res; 8: 194-197

[32] Koeppen-Schomerus, G., Wardle, J., Plomin, R.(2001). A genetic analysis of weight and overweight in 4-year-old twin pairs. Int J Obes Relat Metab Disord; 25: 838-844.

[33] Pietilainen, K.H., Kaprio, J., Rissanen, A., Winter,T., Rimpela, A., Viken, R.J. et al (1999).Distribution and heritability of BMI in Finnish adolescents aged 16y and 17y: a study of 4884 twins and 2509 singletons. Int J Obes Relat Metab Disord; 23: 107-115.

[34] Fesinmeyer, M.D., North, K.E., Ritchie, M.D., Lim,U., Franceschini, N., Wilkens, L.R. et al.(2013).Genetic risk factors for BMI and obesity in an ethnically diverse population: results from the population architecture using genomics and epidemiology (PAGE) study. Obesity (Silver Spring); 21:835-846

[35] Poulsen, P., Vaag, A., Kyvik, K., Beck-Nielsen, H.(2001). Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia, 44:537-543.

[36] Wardle, J., Carnell, S., Haworth, C.M., Plomin, R.(2008). Evidence for a strong genetic influence on childhood adiposity despite the force of the obesogenic environment. Am J Clin Nutr, 87:398-404.

[37] Herrera B.M., Lindgren C.M. (2010). The Genetics of Obesity. Curr Diab Rep 10:498–505 DOI 10.1007/s11892-010-0153-z.

[38] Moll, P.P., Burns, T.L., Lauer, R.M. (1991). The genetic and environmental sources of body mass index variability: the Muscatine Ponderosity Family Study.Am J Hum Genet, 49:1243-1255.

[39] Farooqi, I.S., Keogh, J.M., Yeo, G.S., Lank, E.J.,Cheetham, T., O’Rahilly, S. (2003). Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med.20;348(12):1085-95.

[40] Bonnefond, A. et al., (2016). Eating Behavior,Low-Frequency Functional Mutations in the Melanocortin-4 Receptor (MC4R) Gene, and Outcomes of Bariatric Operations: A 6-Year Prospective Study.Diabetes Care; 39(8): 1384-1392.

[41] Lepsen, E.W., et al. (2018) Patients with Obesity Caused by Melanocortin-4 Receptor Mutations Can Be Treated with a Glucagon-like Peptide-1 Receptor Agonis. Cell Metabolism: 28, 23-32.

[42] Collet, T., et al. (2017). Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency. Molecular Metabolism Volume 6,Issue 10; 1321-1329.



DOI: https://doi.org/10.30564/jer.v3i1.2977

Refbacks

  • There are currently no refbacks.
Copyright © 2021 Onur Oral, George Nomikos, Nikitas Nomikos


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.